In this blog we’ll explore these platforms’ tools for view settings adjustment for fluorescent images and the integrated Figure Maker tool. Together, these features equip researchers to accurately observe and convey the complexity of their samples and the details of their analysis.
Albuquerque, NM, July 8, 2025 – Indica Labs, the global leader in AI-powered digital pathology software and services, today announces that their Pharma Services team is offering quantitative image analysis studies designed and performed to Good Clinical Practice (GCP) standards.
Indica Labs’ Pharma Services Launches GCP-Compliant Image Analysis Service Read More »
Migrating from Aperio eSlide Manager to Indica Labs HALO Image Management Systems
Migrating from Aperio eSlide Manager to Indica Labs HALO Image Management Systems Read More »
Implementation of the Segment Anything Foundation Model in HALO AI
Implementation of the Segment Anything Foundation Model in HALO AI Read More »
26 – 28 June 2025 | Visit us at booth #19 for a live demonstration of the latest developments across our HALO clinical and life science products on June 26-28 or prebook a meeting at our booth.
11 June 2025 | Learn the basics of multiplex fluorescence image analysis!
Getting Started with Multiplex Fluorescence Image Analysis in HALO® Read More »
Extracting biological insights from highly multiplexed data requires both powerful image analysis tools and intuitive methods to navigate high-dimensional data. In this blog, we’ll cover the basics of dimensionality reduction and unsupervised clustering and explore our new High Dimensional Analysis module.
Unlocking Deeper Insights with the HALO® High Dimensional Analysis Module Read More »
Albuquerque, NM, April 30, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an update to their Breast IHC AI suite, an image analysis tool used for the quantification of HER2, ER, PR, and Ki67 within AI-identified, tumor regions, of breast cancer tissue specimens. The HER2 algorithm will now include functionality for the detection of low and ultralow HER2 expression in breast cancer.
Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today the expansion of their macrodissection suite with the launch of CRC Macrodissect AI.
Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI Read More »
Albuquerque, NM and Hørsholm, Denmark, April 9, 2025 – Indica Labs and Visiopharm today announce the successful integration of Visiopharm’s Discovery image analysis software into Indica’s collaborative image management platform, HALO Link. The integration will enable laboratories to create a customized digital pathology ecosystem optimized for their unique image analysis and collaboration needs.
